Inconsistent and incomplete retraction of published research: A cross-sectional study on Covid-19 retractions and recommendations to mitigate risks for research, policy and practice.

Geoff Frampton, Lois Woods, David Alexander Scott
Author Information
  1. Geoff Frampton: Southampton Health Technology Assessments Centre (SHTAC), Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. ORCID
  2. Lois Woods: Southampton Health Technology Assessments Centre (SHTAC), Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  3. David Alexander Scott: Southampton Health Technology Assessments Centre (SHTAC), Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Abstract

BACKGROUND: Retraction of published research can reduce the dissemination of incorrect or misleading information, but concerns have been raised about the clarity and rigor of the retraction process. Failure to clearly and consistently retract research has several risks, for example discredited or erroneous research may inform health research studies (e.g. clinical trials), policies and practices, potentially rendering these unreliable.
OBJECTIVE: To investigate consistency and clarity of research retraction, based on a case study of retracted Covid-19 research.
STUDY DESIGN: A cross-sectional study of retracted Covid-19 articles reporting empirical research findings, based on searches of Medline, Embase and Scopus on 10th July and 19th December 2020.
KEY RESULTS: We included 46 retracted Covid-19 articles. The number eligible for inclusion nearly doubled, from 26 to 46, in five months. Most articles (67%) were retracted from scientific journals and the remainder from preprint servers. Key findings: (1) reasons for retraction were not reported in 33% (15/46) of cases; (2) time from publication to retraction could not be determined in 43% (20/46) of cases; (3) More than half (59%) of retracted Covid-19 articles (27/46) remained available as original unmarked electronic documents after retraction (33% as full text and 26% as an abstract only). Sources of articles post-retraction were preprint servers, ResearchGate and, less commonly, websites including PubMed Central and the World Health Organization. A retracted journal article which controversially claimed a link between 5G technology and Covid-19 remains available in its original full text from at least 60 different websites.
CONCLUSIONS: The retraction process is inconsistent and often ambiguous, with more than half of retracted Covid-19 research articles remaining available, unmarked, from a wide range of online sources. There is an urgent need to improve guidance on the retraction process and to extend this to cover preprint servers. We provide structured recommendations to address these concerns and to reduce the risks that arise when retracted research is inappropriately cited.

References

  1. BMJ. 2010 Mar 23;340:c332 [PMID: 20332509]
  2. PLoS One. 2020 Sep 3;15(9):e0238679 [PMID: 32881950]
  3. Acad Med. 1992 Feb;67(2):109-13 [PMID: 1546986]
  4. Nature. 2020 Jun;582(7811):160 [PMID: 32504025]
  5. J Med Libr Assoc. 2012 Jul;100(3):184-9 [PMID: 22879807]
  6. J Biol Regul Homeost Agents. 2020 Jul 16;34(4): [PMID: 32746604]
  7. Travel Med Infect Dis. 2020 Apr 11;:101665 [PMID: 32283217]
  8. Sci Rep. 2013 Nov 06;3:3146 [PMID: 24192909]
  9. JAMA. 1990 Mar 9;263(10):1420-3 [PMID: 2406475]
  10. J Evid Based Med. 2021 Feb;14(1):56-64 [PMID: 33595200]
  11. Clin Imaging. 2020 May 15;: [PMID: 32425336]
  12. J Med Ethics. 2011 Sep;37(9):567-70 [PMID: 21486985]
  13. J Med Ethics. 2020 Dec;46(12):803-807 [PMID: 33004545]
  14. Med Health Care Philos. 2021 Mar;24(1):21-26 [PMID: 33216274]
  15. J Hosp Infect. 2021 Mar;109:40-43 [PMID: 33169676]
  16. J Clin Orthop Trauma. 2020 May;11(Suppl 3):S304-S306 [PMID: 32405191]
  17. Eur J Clin Invest. 2020 Mar 23;:e13223 [PMID: 32202659]
  18. Infect Immun. 2011 Oct;79(10):3855-9 [PMID: 21825063]
  19. Curr Med Res Opin. 2010 Apr;26(4):843-7 [PMID: 20136577]
  20. PLoS Med. 2007 Oct 16;4(10):e296 [PMID: 17941714]
  21. Ann Intern Med. 2020 Jul 7;173(1):W22-W23 [PMID: 32251511]
  22. Asian J Psychiatr. 2020 Dec;54:102482 [PMID: 33271739]
  23. JAMA. 1998 Jul 15;280(3):296-7 [PMID: 9676689]
  24. Free Radic Biol Med. 2020 Jul 15;: [PMID: 32679367]
  25. Ann Diagn Pathol. 2020 Jun;46:151529 [PMID: 32361635]
  26. Int J Nurs Stud. 2020 May 16;:103635 [PMID: 32425239]
  27. Zhonghua Er Ke Za Zhi. 2020 Feb 17;58(0):E008 [PMID: 32062875]
  28. JAMA. 2020 Nov 10;324(18):1840-1843 [PMID: 33170226]
  29. Science. 2020 Jun 5;368(6495):1041-1042 [PMID: 32499418]
  30. N Engl J Med. 2020 Jun 18;382(25):e102 [PMID: 32356626]
  31. PLoS One. 2012;7(10):e44118 [PMID: 23115617]
  32. Scientometrics. 2020;125(1):819-822 [PMID: 32836531]
  33. PLoS One. 2016 Oct 5;11(10):e0163588 [PMID: 27706245]
  34. Ann Thorac Surg. 2009 Feb;87(2):670 [PMID: 19161816]
  35. Allergy. 2020 Oct;75(10):2542-2547 [PMID: 32434272]
  36. Science. 2018 Oct 26;362(6413):394 [PMID: 30361354]
  37. Korean J Anesthesiol. 2020 Oct;73(5):468 [PMID: 32919439]
  38. BMJ. 2019 Jun 5;365:l2301 [PMID: 31167753]
  39. Int J Ment Health Nurs. 2021 Feb;30(1):350 [PMID: 32779356]
  40. Med J Aust. 2006 Aug 7;185(3):152-4 [PMID: 16893357]
  41. Am J Respir Crit Care Med. 2020 Oct 7;: [PMID: 33026820]
  42. BMJ. 2020 May 12;369:m1847 [PMID: 32398241]
  43. Psychol Health Med. 2021 Jan;26(1):23-34 [PMID: 32286091]
  44. Account Res. 2021 Jan;28(1):47-53 [PMID: 32573274]
  45. PLoS One. 2019 Jun 13;14(6):e0217918 [PMID: 31194762]
  46. Pulmonology. 2021 Mar-Apr;27(2):97-106 [PMID: 33281107]
  47. Bull Med Libr Assoc. 1999 Oct;87(4):437-43 [PMID: 10550028]
  48. JACC Case Rep. 2020 May 27;: [PMID: 32838330]
  49. Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17028-33 [PMID: 23027971]
  50. Science. 2018 Oct 26;362(6413):390-393 [PMID: 30361352]
  51. Sci Total Environ. 2020 Oct 8;:142830 [PMID: 33071142]
  52. J Med Ethics. 2008 Nov;34(11):807-9 [PMID: 18974415]
  53. Rev Neurol (Paris). 2020 Sep 15;: [PMID: 33039152]
  54. Cell Mol Immunol. 2020 Apr 7;:554 [PMID: 32265513]
  55. Ann Intern Med. 2013 Feb 5;158(3):200-7 [PMID: 23295957]
  56. Ann Clin Lab Sci. 2020 May;50(3):299-307 [PMID: 32581016]
  57. Nature. 2011 Oct 05;478(7367):26-8 [PMID: 21979026]
  58. N Engl J Med. 2020 Jun 18;382(25):2462-2464 [PMID: 32356625]
  59. J Med Ethics. 2011 Apr;37(4):249-53 [PMID: 21186208]
  60. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Mar 05;41(4):485-488 [PMID: 32133832]
  61. BMJ. 2021 Mar 29;372:n160 [PMID: 33781993]
  62. Res Social Adm Pharm. 2021 Jan;17(1):1964-1966 [PMID: 32317154]
  63. J Microbiol Biol Educ. 2014 Dec 15;15(2):151-4 [PMID: 25574267]
  64. Diabetes Technol Ther. 2020 May 12;: [PMID: 32396400]
  65. Heart Lung Circ. 2020 Aug 24;: [PMID: 32917551]
  66. Am J Pathol. 2020 Sep;190(9):1881-1887 [PMID: 32628931]
  67. Science. 2020 Jun 12;368(6496):1167-1168 [PMID: 32527807]
  68. Lancet Glob Health. 2020 May;8(5):e627-e630 [PMID: 32220289]
  69. Lancet. 2020 Jun 13;395(10240):1820 [PMID: 32511943]
  70. Lancet. 2020 Sep 19;396(10254):805 [PMID: 32950077]
  71. Clin Epidemiol. 2020 Dec 21;12:1403-1420 [PMID: 33376409]
  72. J Clin Epidemiol. 2020 Jul;123:120-126 [PMID: 32330521]
  73. Ann Med Surg (Lond). 2020 Jun 14;: [PMID: 32837717]
  74. J Eval Clin Pract. 2021 Feb;27(1):16-21 [PMID: 33094906]
  75. Res Integr Peer Rev. 2017 May 12;2:5 [PMID: 29451549]
  76. Lancet. 2018 Jun 23;391(10139):2482-2483 [PMID: 29976456]
  77. BMC Res Notes. 2013 Jun 19;6:238 [PMID: 23782596]
  78. Sci Eng Ethics. 2010 Jun;16(2):251-61 [PMID: 19597966]

MeSH Term

COVID-19
Humans
Cross-Sectional Studies
Retraction of Publication as Topic
SARS-CoV-2
Biomedical Research
Scientific Misconduct